Key facts
- This page summarizes Subaweerage Dias's Form 4 filing for SPRUCE BIOSCIENCES, INC. (SPRB).
- 2 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 20 Dec 2021, 20:08.
Subaweerage Dias - 16 Dec 2021 Form 4 Insider Report for SPRUCE BIOSCIENCES, INC. (SPRB)
- Reporting relationship
- Chief Medical Officer
- Issuer ticker
- SPRB
- Reported as of
- 16 Dec 2021
- Net transaction value
- $0
- Reporting owner signature
- /s/ Samir Gharib, Power of Attorney
Source evidence
Original filing metadata and source links for verification.
3 source fields
Reporting owner
1 detail
Key filing fact
Subaweerage Dias filed Form 4 for SPRUCE BIOSCIENCES, INC. (SPRB) on 20 Dec 2021.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
SPRB
transaction
Derivative
Employee Stock Option (right to buy)
Award
- Transaction value
- $0
- Shares
- +75,000
- Change %
- Price
- $0.000000
- Shares after
- 75,000
- Date
- 16 Dec 2021
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 75,000
- Exercise price
- $2.48
- Footnotes
- F1
SPRB
transaction
Derivative
Restricted Stock Units
Award
- Transaction value
- $0
- Shares
- +20,000
- Change %
- Price
- $0.000000
- Shares after
- 20,000
- Date
- 16 Dec 2021
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 20,000
- Exercise price
- Footnotes
- F2, F3, F4
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 4 footnotes
Footnote F1
1/48th of the shares vest on a monthly basis from December 16, 2021, subject to the Reporting Person's Continuous Service (as defined in the Issuer's 2020 Equity Incentive Plan).
Footnote F2
Each restricted stock unit represents a contingent right to receive one share of SPRB common stock.
Footnote F3
10,000 of the restricted stock units shall vest 25% on June 30, 2022, 25% shall vest on December 31, 2022 and 50% shall vest on June 30, 2023, subject to the Reporting Person's Continuous Service (as defined in the Issuer's 2020 Equity Incentive Plan).
Footnote F4
10,000 of the restricted stock units shall vest upon the achievement of specified performance goals.